National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov
In English | En español
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Dictionary of Cancer Terms
In English   En español
Page Options
Print This Page
More NCI Dictionaries
NCI Drug Dictionary

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
In English   En español

Rilutek (RY-loo-tek)

 A drug used to treat a nerve disease called amyotrophic lateral sclerosis (ALS). It is also being studied in the treatment of melanoma (a type of skin cancer). Rilutek blocks the release of a substance that melanoma cells need to grow. It is a type of glutamate release inhibitor. Also called riluzole.



Previous Definitions:ribonucleic acid, ribonucleotide reductase inhibitor, Richter syndrome, Richter transformation, rifampin
Next Definitions:riluzole, risedronate, risk factor, risk ratio, ritonavir

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov